Content about Investment

PITTSBURGH — Mylan has appointed its president and a former Goldman Sachs & Co. partner to its board, the generic drug maker said Monday.

Mylan announced the appointment of president Rajiv Malik and former Goldman Sachs partner Melina Higgins to its board.

PLEASANTON, Calif. — Safeway on Monday announced the appointment of Peter Bocian as its new executive vice president and CFO. Bocian, 58, will oversee the company's financial functions including accounting, tax, audit, treasury, investor relations, planning and business development. He will report directly to Robert Edwards, Safeway's president, and will assume his new responsibilities on Feb. 19.

NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

Other companies who have been invited to bid include Merck and Pfizer. 

PARSIPPANY, N.J. — Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.

Watson said that president and CEO Paul Bisaro would provide an overview and update of the company's business at the 2013 Goldman Sachs "Healthcare CEOs Unscripted: A View from the Top" conference, scheduled for Jan. 3, 2013, at the Goldman Sachs Conference Center in New York.

Six days later, on Jan. 9, Bisaro will present at the annual J.P. Morgan Healthcare Conference, at the Westin St. Francis Hotel in San Francisco.

CITY OF INDUSTRY and AZUSA, Calif. — Markwins announced on Wednesday that it has acquired all of the outstanding securities of Physicians Formula for $75 million or $4.90 per share in cash.

TORONTO – Waiving $2 co-pays in Ontario is a big piece of the reason behind a 6% lift in prescriptions dispensed for the third quarter through Oct. 6, Shoppers Drug Mart reported Tuesday afternoon. It's all part of a strategy to drive more seniors — and their prescriptions — into the store, executives told analysts. "We're seeing store gains across the country," noted Domenic Pilla, Shoppers president and CEO. "The incremental script count is above our initial expectations," he said.

SAN ANTONIO — Consumers plan to buy more gifts this year, according to a recent survey commissioned by USAA and released Monday. The fourth annual USAA holiday spending survey indicated that consumer sentiment toward holiday budgeting has become more positive in 2012 when compared to 2011 (53% vs. 45%).

Dallas -- A survey released Tuesday by Chase Paymentech, a subsidiary of JPMorgan Chase & Co., found that online companies are expecting the 2012 holiday shopping season to be better than last year.

According to the Chase Paymentech eHoliday Shopping Monitor, 59% of e-commerce companies surveyed expect better sales volume this season than in 2011, while almost half (47%) expect it to be better than pre-recession levels in 2007.

TORONTO — In support of Shoppers Drug Mart’s ongoing commitment to women’s health, the company and its associate-owners have announced that the 11th annual Tree of Life campaign will run from Sept. 29 to Oct. 26.

The national four-week campaign has raised more than $17 million dollars in the past, with the projected goal of $2.3 million this year to help fund local women’s charities across Canada.

With an army of 26,000-plus beauty advisers, the expansion of the LOOK Boutique concept, the expertise from its online beauty engine Beauty.com and the Walgreens-Alliance Boots transaction, Walgreens is giving the U.S. mass market beauty world a makeover like no other. 


Going back even as little as a few years ago, Walgreens wasn’t exactly making waves in the beauty industry, as its beauty department was quite typical of that found within a traditional U.S. drug store. How times have changed.


NEW YORK — Revlon’s board has declared a regular dividend of approximately 16.5 cents per share on the Series A Preferred Stock for the period from July 9 through Oct. 8.

This regular dividend is payable on Oct. 8 to holders of record of the Series A Preferred Stock at the close of business on Sept. 28.

DEERFIELD, Ill. — Walgreens on Monday announced that it has priced an underwritten public offering of senior notes, the net proceeds from which will be used to repay — in full — money that was borrowed to fund the cash consideration in its acquisition of a 45% stake in Alliance Boots and for general corporate purposes, including its previously announced USA Drug acquisition.

The senior notes consist of:

• $550 million of floating rate notes due 2014;

• $750 million of 1% notes due 2015;